과제정보
This work was supported by the National Research foundation of Korea (NRF) grant (NRF-2022R1A2C1005371) and Korea National Institute of Health (KNIH) 2022-ER-1304-01 grant funded by the Korea government.
참고문헌
- El-Serag HB and Rudolph KL (2007) Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology 132, 2557-2576 https://doi.org/10.1053/j.gastro.2007.04.061
- Sakurai T and Kudo M (2013) Molecular link between liver fibrosis and hepatocellular carcinoma. Liver Cancer 2, 365-366 https://doi.org/10.1159/000343851
- Kwon OS, Choi SH and Kim JH (2015) Inflammation and hepatic fibrosis, then hepatocellular carcinoma. Korean J Gastroenterol 66, 320-324 https://doi.org/10.4166/kjg.2015.66.6.320
- Filozof C, Goldstein BJ, Williams RN and Sanyal A (2015) Non-alcoholic steatohepatitis: limited available treatment options but promising drugs in development and recent progress towards a regulatory approval pathway. Drugs 75, 1373-1392 https://doi.org/10.1007/s40265-015-0437-3
- Llovet JM, Castet F, Heikenwalder M et al (2022) Immunotherapies for hepatocellular carcinoma. Nat Rev Clin Oncol 19, 151-172 https://doi.org/10.1038/s41571-021-00573-2
- Luo XY, Wu KM and He XX (2021) Advances in drug development for hepatocellular carcinoma: clinical trials and potential therapeutic targets. J Exp Clin Cancer Res 40, 172
- Kammerer S (2021) Three-dimensional liver culture systems to maintain primary hepatic properties for toxicological analysis in vitro. Int J Mol Sci 22, 10214
- Song Y, Kim SH, Kim KM, Choi EK, Kim J and Seo HR (2016) Activated hepatic stellate cells play pivotal roles in hepatocellular carcinoma cell chemoresistance and migration in multicellular tumor spheroids. Sci Rep 6, 36750
- Barry AE, Baldeosingh R, Lamm R et al (2020) Hepatic stellate cells and hepatocarcinogenesis. Front Cell Dev Biol 8, 709
- Tsuchida T and Friedman SL (2017) Mechanisms of hepatic stellate cell activation. Nat Rev Gastroenterol Hepatol 14, 397-411 https://doi.org/10.1038/nrgastro.2017.38
- Ali E, Trailin A, Ambrozkiewicz F, Liska V and Hemminki K (2022) Activated hepatic stellate cells in hepatocellular carcinoma: their role as a potential target for future therapies. Int J Mol Sci 23, 15292
- Thompson AI, Conroy KP and Henderson NC (2015) Hepatic stellate cells: central modulators of hepatic carcinogenesis. BMC Gastroenterol 15, 63
- Myojin Y, Hikita H, Sugiyama M et al (2021) Hepatic stellate cells in hepatocellular carcinoma promote tumor growth via growth differentiation factor 15 production. Gastroenterology 160, 1741-1754 e1716
- Lee SY, Kim S, Choi I et al (2022) Inhibition of 11beta-hydroxysteroid dehydrogenase 1 relieves fibrosis through depolarizing of hepatic stellate cell in NASH. Cell Death Dis 13, 1011 https://doi.org/10.1038/s41419-022-05452-x
- Choi KJ, Nam JK, Kim JH, Choi SH and Lee YJ (2020) Endothelial-to-mesenchymal transition in anticancer therapy and normal tissue damage. Exp Mol Med 52, 781-792 https://doi.org/10.1038/s12276-020-0439-4
- Song Y, Lee SY, Kim AR et al (2019) Identification of radiation-induced EndMT inhibitors through cell-based phenomic screening. FEBS Open Bio 9, 82-91 https://doi.org/10.1002/2211-5463.12552
- Song S, Zhang R, Cao W et al (2019) Foxm1 is a critical driver of TGF-beta-induced EndMT in endothelial cells through Smad2/3 and binds to the Snail promoter. J Cell Physiol 234, 9052-9064
- Mahmoud MM, Serbanovic-Canic J, Feng S et al (2017) Shear stress induces endothelial-to-mesenchymal transition via the transcription factor Snail. Sci Rep 7, 3375
- Kim SH, Song Y and Seo HR (2019) GSK-3beta regulates the endothelial-to-mesenchymal transition via reciprocal crosstalk between NSCLC cells and HUVECs in multicellular tumor spheroid models. J Exp Clin Cancer Res 38, 46
- Lee M, Song Y, Choi I et al (2021) Expression of HYOU1 via reciprocal crosstalk between NSCLC cells and HUVECs control cancer progression and chemoresistance in tumor spheroids. Mol Cells 44, 50-62 https://doi.org/10.14348/molcells.2020.0212
- Tian Z, Hou X, Liu W, Han Z and Wei L (2019) Macrophages and hepatocellular carcinoma. Cell Biosci 9, 79
- Arvanitakis K, Koletsa T, Mitroulis I and Germanidis G (2022) Tumor-associated macrophages in hepatocellular carcinoma pathogenesis, prognosis and therapy. Cancers (Basel) 14, 226
- Xiao P, Long X, Zhang L et al (2018) Neurotensin/IL-8 pathway orchestrates local inflammatory response and tumor invasion by inducing M2 polarization of Tumor-Associated macrophages and epithelial-mesenchymal transition of hepatocellular carcinoma cells. Oncoimmunology 7, e1440166
- Yin Z, Huang J, Ma T et al (2017) Macrophages activating chemokine (C-X-C motif) ligand 8/miR-17 cluster modulate hepatocellular carcinoma cell growth and metastasis. Am J Transl Res 9, 2403-2411
- Huang Y, Ge W, Zhou J, Gao B, Qian X and Wang W (2021) The role of tumor associated macrophages in hepatocellular carcinoma. J Cancer 12, 1284-1294 https://doi.org/10.7150/jca.51346
- Dong P, Ma L, Liu L et al (2016) CD86(+)/CD206(+), Diametrically polarized tumor-associated macrophages, predict hepatocellular carcinoma patient prognosis. Int J Mol Sci 17, 320
- Kubo N, Araki K, Kuwano H and Shirabe K (2016) Cancer-associated fibroblasts in hepatocellular carcinoma. World J Gastroenterol 22, 6841-6850 https://doi.org/10.3748/wjg.v22.i30.6841
- Jia W, Liang S, Cheng B and Ling C (2021) The role of cancer-associated fibroblasts in hepatocellular carcinoma and the value of traditional chinese medicine treatment. Front Oncol 11, 763519
- Duran A, Hernandez ED, Reina-Campos M et al (2016) p62/SQSTM1 by binding to vitamin D receptor inhibits hepatic stellate cell activity, fibrosis, and liver cancer. Cancer Cell 30, 595-609 https://doi.org/10.1016/j.ccell.2016.09.004
- Zhao Z, Bai S, Wang R et al (2019) Cancer-associated fibroblasts endow stem-like qualities to liver cancer cells by modulating autophagy. Cancer Manag Res 11, 5737-5744 https://doi.org/10.2147/CMAR.S197634
- Song Y, Kim JS, Kim SH et al (2018) Patient-derived multicellular tumor spheroids towards optimized treatment for patients with hepatocellular carcinoma. J Exp Clin Cancer Res 37, 109
- Al Hrout A, Cervantes-Gracia K, Chahwan R and Amin A (2022) Modelling liver cancer microenvironment using a novel 3D culture system. Sci Rep 12, 8003
- Lee KH and Kim TH (2021) Recent advances in multicellular tumor spheroid generation for drug screening. Biosensors (Basel) 11, 445
- Wang Q, Liu J, Yin W et al (2022) Generation of multicellular tumor spheroids with micro-well array for anticancer drug combination screening based on a valuable biomarker of hepatocellular carcinoma. Front Bioeng Biotechnol 10, 1087656
- Song Y, Kim S, Heo J et al (2021) Identification of hepatic fibrosis inhibitors through morphometry analysis of a hepatic multicellular spheroids model. Sci Rep 11, 10931
- Lim JTC, Kwang LG, Ho NCW et al (2022) Hepatocellular carcinoma organoid co-cultures mimic angiocrine crosstalk to generate inflammatory tumor microenvironment. Biomaterials 284, 121527
- Doumba PP, Nikolopoulou M, Gomatos IP, Konstadoulakis MM and Koskinas J (2013) Co-culture of primary human tumor hepatocytes from patients with hepatocellular carcinoma with autologous peripheral blood mononuclear cells: study of their in vitro immunological interactions. BMC Gastroenterol 13, 17
- Kim S, Lee M, Song Y et al (2021) Argininosuccinate synthase 1 suppresses tumor progression through activation of PERK/eIF2alpha/ATF4/CHOP axis in hepatocellular carcinoma. J Exp Clin Cancer Res 40, 127
- Makridakis M and Vlahou A (2010) Secretome proteomics for discovery of cancer biomarkers. J Proteomics 73, 2291-2305 https://doi.org/10.1016/j.jprot.2010.07.001
- Lee SY, Kim S, Song Y et al (2022) Sorbitol dehydrogenase induction of cancer cell necroptosis and macrophage polarization in the HCC microenvironment suppresses tumor progression. Cancer Lett 551, 215960
- Rawal P, Tripathi DM, Nain V and Kaur S (2022) VEGFmediated tumour growth and EMT in 2D and 3D cell culture models of hepatocellular carcinoma. Oncol Lett 24, 315
- Chen R, Dong Y, Xie X et al (2014) Screening candidate metastasis-associated genes in three-dimensional HCC spheroids with different metastasis potential. Int J Clin Exp Pathol 7, 2527-2535
- Kimlin LC, Casagrande G and Virador VM (2013) In vitro three-dimensional (3D) models in cancer research: an update. Mol Carcinog 52, 167-182 https://doi.org/10.1002/mc.21844
- Chen RX, Song HY, Dong YY et al (2014) Dynamic expression patterns of differential proteins during early invasion of hepatocellular carcinoma. PLoS One 9, e88543
- Lee SH, Nam JK, Park JK, Lee JH, Min do S and Kuh HJ (2014) Differential protein expression and novel biomarkers related to 5-FU resistance in a 3D colorectal adenocarcinoma model. Oncol Rep 32, 1427-1434 https://doi.org/10.3892/or.2014.3337
- Song Y, Kim JS, Choi EK, Kim J, Kim KM and Seo HR (2017) TGF-beta-independent CTGF induction regulates cell adhesion mediated drug resistance by increasing collagen I in HCC. Oncotarget 8, 21650-21662 https://doi.org/10.18632/oncotarget.15521
- Hsiao YC, Chu LJ, Chen JT, Yeh TS and Yu JS (2017) Proteomic profiling of the cancer cell secretome: informing clinical research. Expert Rev Proteomics 14, 737-756 https://doi.org/10.1080/14789450.2017.1353913
- Jeon D, Choi WM, Kim JS et al (2021) Serum sorbitol dehydrogenase as a novel prognostic factor for hepatocellular carcinoma after surgical resection. Cancers (Basel) 13, 6143
- Zanoni M, Pignatta S, Arienti C, Bonafe M and Tesei A (2019) Anticancer drug discovery using multicellular tumor spheroid models. Expert Opin Drug Discov 14, 289-301 https://doi.org/10.1080/17460441.2019.1570129
- Thanapirom K, Caon E, Papatheodoridi M et al (2021) Optimization and validation of a novel three-dimensional co-culture system in decellularized human liver scaffold for the study of liver fibrosis and cancer. Cancers (Basel) 13, 4936
- Lafnoune A, Lee SY, Heo JY et al (2022) Anti-cancer activity of buthus occitanus venom on hepatocellular carcinoma in 3D cell culture. Molecules 27, 2219
- Lafnoune A, Lee SY, Heo JY et al (2021) Anti-cancer effect of moroccan cobra naja haje venom and its fractions against hepatocellular carcinoma in 3D cell culture. Toxins (Basel) 13, 402
- Liao W, Yang W, Xu J et al (2021) Therapeutic potential of CUDC-907 (fimepinostat) for hepatocarcinoma treatment revealed by tumor spheroids-based drug screening. Front Pharmacol 12, 658197
- Hou J, Hong Z, Feng F et al (2017) A novel chemotherapeutic sensitivity-testing system based on collagen gel droplet embedded 3D-culture methods for hepatocellular carcinoma. BMC Cancer 17, 729
- Song Y, Lee SY, Kim S et al (2020) Inhibitors of Na(+)/K(+) ATPase exhibit antitumor effects on multicellular tumor spheroids of hepatocellular carcinoma. Sci Rep 10, 5318
- Rehman M, Vodret S, Braga L et al (2019) High-throughput screening discovers antifibrotic properties of haloperidol by hindering myofibroblast activation. JCI Insight 4, e123987
- Arai K, Eguchi T, Rahman MM et al (2016) A novel high-throughput 3D screening system for EMT inhibitors: a pilot screening discovered the EMT inhibitory activity of CDK2 inhibitor SU9516. PLoS One 11, e0162394
- Di Sanzo M, Cipolloni L, Borro M et al (2017) Clinical applications of personalized medicine: a new paradigm and challenge. Curr Pharm Biotechnol 18, 194-203 https://doi.org/10.2174/1389201018666170224105600
- Fong ELS, Toh TB, Lin QXX et al (2018) Generation of matched patient-derived xenograft in vitro-in vivo models using 3D macroporous hydrogels for the study of liver cancer. Biomaterials 159, 229-240 https://doi.org/10.1016/j.biomaterials.2017.12.026
- Zhang L, Liu F, Weygant N et al (2021) A novel integrated system using patient-derived glioma cerebral organoids and xenografts for disease modeling and drug screening. Cancer Lett 500, 87-97 https://doi.org/10.1016/j.canlet.2020.12.013
- Imamura Y, Mukohara T, Shimono Y et al (2015) Comparison of 2D- and 3D-culture models as drug-testing platforms in breast cancer. Oncol Rep 33, 1837-1843 https://doi.org/10.3892/or.2015.3767
- Kaur G, Evans DM, Teicher BA and Coussens NP (2021) Complex tumor spheroids, a tissue-mimicking tumor model, for drug discovery and precision medicine. SLAS Discov 26, 1298-1314 https://doi.org/10.1177/24725552211038362
- Kronemberger GS, Carneiro FA, Rezende DF and Baptista LS (2021) Spheroids and organoids as humanized 3D scaffold-free engineered tissues for SARS-CoV-2 viral infection and drug screening. Artif Organs 45, 548-558 https://doi.org/10.1111/aor.13880
- Hwang KS, Seo EU, Choi N, Kim J and Kim HN (2023) 3D engineered tissue models for studying human-specific infectious viral diseases. Bioact Mater 21, 576-594 https://doi.org/10.1016/j.bioactmat.2022.09.010
- de Dios-Figueroa GT, Aguilera-Marquez JDR, Camacho-Villegas TA and Lugo-Fabres PH (2021) 3D cell culture models in COVID-19 times: a review of 3D technologies to understand and accelerate therapeutic drug discovery. Biomedicines 9, 602
- Salgueiro L, Kummer S, Sonntag-Buck V et al (2022) Generation of human lung organoid cultures from healthy and tumor tissue to study infectious diseases. J Virol 96, e0009822
- Loy LM, Low HM, Choi JY, Rhee H, Wong CF and Tan CH (2022) Variant hepatocellular carcinoma subtypes according to the 2019 WHO classification: an imagingfocused review. AJR Am J Roentgenol 219, 212-223 https://doi.org/10.2214/AJR.21.26982